This Biotech Stock Could Be A Good “Bad News Buy”
When it comes to the biotech stock that’s the focus of today’s article, which plummeted in mid-October when the company abruptly pulled the plug on…
October Investments
The Current Case For Cash
Could cash prove to be the biggest winner in your portfolio for 2018? The S&P 500 and Dow – and bonds – are currently in…